# Stewart A. Factor

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stewart-a-factor/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,232 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 87 |
| i10-index | 279 |
| Last Known Institution | Emory University |
| OpenAlex ID | https://openalex.org/A5054911069 |
| ORCID iD | https://orcid.org/0000-0002-0449-973X |
| Works | 500 |

## Researcher papers

- [The Parkinson Progression Marker Initiative (PPMI)](https://scholariq.org/papers/the-parkinson-progression-marker-initiative-ppmi/)
- [Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database](https://scholariq.org/papers/comprehensive-research-synopsis-and-systematic-meta-analyses-in-parkinson-s/)
- [Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease](https://scholariq.org/papers/effect-of-deutetrabenazine-on-chorea-among-patients-with-huntington-disease/)
- [CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion](https://scholariq.org/papers/cag-repeat-expansion-in-huntington-disease-determines-age-at-onset-in-a-fully/)
- [A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease](https://scholariq.org/papers/a-randomized-double-blind-placebo-controlled-trial-of-antidepressants-in/)
- [Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls](https://scholariq.org/papers/longitudinal-csf-biomarkers-in-patients-with-early-parkinson-disease-and-healthy/)
- [Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study](https://scholariq.org/papers/clinical-and-dopamine-transporter-imaging-characteristics-of-non-manifest-lrrk2/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)

## Researcher university

- [Emory University](https://scholariq.org/institutions/emory-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.